Personal Values, Wishes, and Goals of Patients with Advanced Lung Cancer: A Qualitative Study

被引:0
|
作者
Koenig, Mara [1 ,2 ,3 ]
Siegle, Anja [1 ,2 ,3 ,4 ]
Unsoeld, Laura [1 ,2 ,3 ]
Ludwig, Jan Ole [1 ,2 ,3 ]
Deis, Nicole [1 ,2 ,3 ]
Thomas, Michael [1 ,2 ,3 ]
Poss-Doering, Regina [5 ]
Villalobos, Matthias [1 ,2 ,3 ]
机构
[1] Univ Hosp Heidelberg, Dept Thorac Oncol, Heidelberg, Germany
[2] Translat Lung Res Ctr Heidelberg TLRC H, Heidelberg, Germany
[3] German Ctr Lung Res DZL, Heidelberg, Germany
[4] Baden Wuerttemberg Cooperat State Univ Stuttgart D, Fac Business & Hlth, Dept Hlth Sci & Management, Stuttgart, Germany
[5] Heidelberg Univ, Dept Gen Med & Hlth Serv Res, Heidelberg, Germany
关键词
END-OF-LIFE; DIGNITY-RELATED DISTRESS; PALLIATIVE CARE; INCURABLE CANCER; OLDER-ADULTS; COMMUNICATION; PREFERENCES; INTERVENTION; PERSPECTIVES; ASSOCIATIONS;
D O I
10.1155/2024/9987322
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Oncology and palliative care guidelines for patients with incurable cancer recommend supporting patients at the end of life (EOL) by considering their personal values, wishes, and goals to facilitate decision making in advance care planning and patient-centered care. It is unclear, though, how to successfully address and integrate personal values in clinical practice. The aim of this study was to explore values, wishes, and goals from the perspective of patients with advanced lung cancer. Methods. Semistructured interviews were conducted with patients with advanced lung cancer and transcribed verbatim. The data were analysed using a structured content analysis. After identification of main categories, values were identified using Schwartz's Theory of Basic Human Values as a theoretical framework. Results. Identified main categories were "the individual in medical care," "living now," and "coming to terms." Values in the dimensions "conservation" and "openness to change" were described concerning patient-physician interaction, therapy goals, preparedness for EOL, and life goals. "Self-transcendence" values mainly related to caring for the burden on relatives. In general, patients showed reluctance in expressing information about personal values when communicating with physicians. Conclusion. Patients with advanced lung cancer engage in various ways to determine how they want and can influence their life and medical care. Different values and the associated wishes and goals play a crucial role in this context and should be taken into account by healthcare providers. The reluctance to express personal information in medical encounters underscores the need for a proactive attitude in physicians and improved interprofessional collaboration. The study was registered in the German register for clinical trials (DRKS00026993).
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Discussing prognosis and treatment goals with patients with advanced cancer: A qualitative analysis of oncologists' language
    Chou, Wen-ying Sylvia
    Hamel, Lauren M.
    Thai, Chan L.
    Debono, David
    Chapman, Robert A.
    Albrecht, Terrance L.
    Penner, Louis A.
    Eggly, Susan
    [J]. HEALTH EXPECTATIONS, 2017, 20 (05) : 1073 - 1080
  • [22] Hard choices: a qualitative study of influences on the treatment decisions made by advanced lung cancer patients
    Thornton, M.
    Parry, M.
    Gill, P.
    Mead, D.
    Macbeth, F.
    [J]. INTERNATIONAL JOURNAL OF PALLIATIVE NURSING, 2011, 17 (02) : 68 - 74
  • [23] Coping with physical and psychological symptoms: a qualitative study of advanced lung cancer patients and their family caregivers
    Mosher, Catherine E.
    Ott, Mary A.
    Hanna, Nasser
    Jalal, Shadia I.
    Champion, Victoria L.
    [J]. SUPPORTIVE CARE IN CANCER, 2015, 23 (07) : 2053 - 2060
  • [24] Coping with physical and psychological symptoms: a qualitative study of advanced lung cancer patients and their family caregivers
    Catherine E. Mosher
    Mary A. Ott
    Nasser Hanna
    Shadia I. Jalal
    Victoria L. Champion
    [J]. Supportive Care in Cancer, 2015, 23 : 2053 - 2060
  • [25] EXPRESSED WISHES FOR EUTHANASIA AND INCIDENCE OF END-OF-LIFE DECISIONS IN ADVANCED LUNG CANCER PATIENTS: A PROSPECTIVE STUDY IN FLANDERS, BELGIUM
    Pardon, Koen
    Deschepper, Reginald
    Vander Stichele, Robert
    Bernheim, Jan L.
    Mortier, Freddy
    Schallier, Denis
    Germonpre, Paul
    Galdermans, Daniella
    Deliens, Luc
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S306 - S307
  • [26] Advanced cancer patients' priorities regarding wishes at the end of life: A randomized controlled study
    Delgado-Guay, Marvin Omar
    Rodriguez-Nunez, Alfredo
    De la Cruz, Vera J.
    Frisbee-Hume, Susan
    Williams, Janet L.
    Wu, Jimin
    Liu, Diane D.
    Fisch, Michael
    Bruera, Eduardo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [27] Core values of patients with advanced cancer considering participation in an early-phase clinical trial: a qualitative study
    van Gurp, Jelle L. P.
    van Lent, Liza G. G.
    Stoel, Nicole
    van der Rijt, Carin C. D.
    de Jonge, Maja J. A.
    Pulleman, Saskia M.
    van Weert, Julia C. M.
    Hasselaar, Jeroen
    [J]. SUPPORTIVE CARE IN CANCER, 2022, 30 (09) : 7605 - 7613
  • [28] Core values of patients with advanced cancer considering participation in an early-phase clinical trial: a qualitative study
    Jelle L. P. van Gurp
    Liza G. G. van Lent
    Nicole Stoel
    Carin C. D. van der Rijt
    Maja J. A. de Jonge
    Saskia M. Pulleman
    Julia C. M. van Weert
    Jeroen Hasselaar
    [J]. Supportive Care in Cancer, 2022, 30 : 7605 - 7613
  • [29] Unmet needs and opportunities for improving care for patients with advanced lung cancer on targeted therapies: a qualitative study
    Al Achkar, Morhaf
    Marchand, Lucille
    Thompson, Matthew
    Chow, Laura Q. M.
    Revere, Debra
    Baldwin, Laura-Mae
    [J]. BMJ OPEN, 2020, 10 (03):
  • [30] Unpredictable episodic breathlessness in patients with advanced chronic obstructive pulmonary disease and lung cancer: a qualitative study
    Linde, P.
    Hanke, G.
    Voltz, R.
    Simon, S. T.
    [J]. SUPPORTIVE CARE IN CANCER, 2018, 26 (04) : 1097 - 1104